AZITRA INC (AZTR) Fundamental Analysis & Valuation

NYSEARCA:AZTR • US05479L3024

0.1916 USD
-0.01 (-6.54%)
At close: Mar 11, 2026
0.194 USD
+0 (+1.25%)
After Hours: 3/11/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AZTR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

AZTR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 519 industry peers in the Biotechnology industry. AZTR may be in some trouble as it scores bad on both profitability and health. AZTR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. AZTR Profitability Analysis

1.1 Basic Checks

  • AZTR had negative earnings in the past year.
  • In the past year AZTR has reported a negative cash flow from operations.
  • AZTR had negative earnings in each of the past 5 years.
  • In the past 5 years AZTR always reported negative operating cash flow.
AZTR Yearly Net Income VS EBIT VS OCF VS FCFAZTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -208.53%, AZTR is doing worse than 88.63% of the companies in the same industry.
  • AZTR has a worse Return On Equity (-393.45%) than 74.37% of its industry peers.
Industry RankSector Rank
ROA -208.53%
ROE -393.45%
ROIC N/A
ROA(3y)-185.51%
ROA(5y)-136.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZTR Yearly ROA, ROE, ROICAZTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 400 -400

1.3 Margins

  • AZTR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZTR Yearly Profit, Operating, Gross MarginsAZTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -50K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. AZTR Health Analysis

2.1 Basic Checks

  • AZTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AZTR has been increased compared to 1 year ago.
  • Compared to 1 year ago, AZTR has an improved debt to assets ratio.
AZTR Yearly Shares OutstandingAZTR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
AZTR Yearly Total Debt VS Total AssetsAZTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • AZTR has an Altman-Z score of -28.91. This is a bad value and indicates that AZTR is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AZTR (-28.91) is worse than 87.48% of its industry peers.
  • AZTR has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of AZTR (0.13) is worse than 63.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -28.91
ROIC/WACCN/A
WACC8.74%
AZTR Yearly LT Debt VS Equity VS FCFAZTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that AZTR should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.23, AZTR is not doing good in the industry: 83.81% of the companies in the same industry are doing better.
  • AZTR has a Quick Ratio of 1.23. This is a normal value and indicates that AZTR is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.23, AZTR is not doing good in the industry: 83.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
AZTR Yearly Current Assets VS Current LiabilitesAZTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AZTR Growth Analysis

3.1 Past

  • AZTR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.82%.
  • AZTR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -98.91%.
  • Measured over the past years, AZTR shows a very negative growth in Revenue. The Revenue has been decreasing by -59.15% on average per year.
EPS 1Y (TTM)-29.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
Revenue 1Y (TTM)-98.91%
Revenue growth 3Y-59.15%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, AZTR will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.26% on average per year.
  • The Revenue is expected to grow by 195.38% on average over the next years. This is a very strong growth
EPS Next Y-886.19%
EPS Next 2Y38.5%
EPS Next 3Y21.47%
EPS Next 5Y18.26%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y195.38%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AZTR Yearly Revenue VS EstimatesAZTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
AZTR Yearly EPS VS EstimatesAZTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

1

4. AZTR Valuation Analysis

4.1 Price/Earnings Ratio

  • AZTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year AZTR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AZTR Price Earnings VS Forward Price EarningsAZTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AZTR Per share dataAZTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AZTR's earnings are expected to grow with 21.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.5%
EPS Next 3Y21.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AZTR Dividend Analysis

5.1 Amount

  • No dividends for AZTR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AZTR Fundamentals: All Metrics, Ratios and Statistics

AZITRA INC

NYSEARCA:AZTR (3/11/2026, 8:04:00 PM)

After market: 0.194 +0 (+1.25%)

0.1916

-0.01 (-6.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners2.1%
Inst Owner Change433.06%
Ins Owners0.03%
Ins Owner Change0%
Market Cap3.10M
Revenue(TTM)7.50K
Net Income(TTM)-8.97M
Analysts82.86
Price Target2.75 (1335.28%)
Short Float %6.02%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.61%
Min EPS beat(2)15.24%
Max EPS beat(2)15.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5329.23%
EPS NY rev (3m)-3980.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 413.6
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.54
EV/EBITDA N/A
EPS(TTM)-15.78
EYN/A
EPS(NY)-1.14
Fwd EYN/A
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS0
BVpS0.14
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -208.53%
ROE -393.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-185.51%
ROA(5y)-136.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.31%
Cap/Sales 200%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z -28.91
F-Score1
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)34.64%
Cap/Depr(5y)206.62%
Cap/Sales(3y)51.41%
Cap/Sales(5y)122.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
EPS Next Y-886.19%
EPS Next 2Y38.5%
EPS Next 3Y21.47%
EPS Next 5Y18.26%
Revenue 1Y (TTM)-98.91%
Revenue growth 3Y-59.15%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y195.38%
EBIT growth 1Y-47.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.02%
OCF growth 3YN/A
OCF growth 5YN/A

AZITRA INC / AZTR FAQ

What is the ChartMill fundamental rating of AZITRA INC (AZTR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AZTR.


What is the valuation status for AZTR stock?

ChartMill assigns a valuation rating of 1 / 10 to AZITRA INC (AZTR). This can be considered as Overvalued.


Can you provide the profitability details for AZITRA INC?

AZITRA INC (AZTR) has a profitability rating of 0 / 10.


How financially healthy is AZITRA INC?

The financial health rating of AZITRA INC (AZTR) is 2 / 10.


What is the earnings growth outlook for AZITRA INC?

The Earnings per Share (EPS) of AZITRA INC (AZTR) is expected to decline by -886.19% in the next year.